. One fourth of mild and moderate-to-severe cases were nonsmokers. Among 7,526 nonsmokers, 4.7 ؎ 0.3% had mild COPD (n ‫؍‬ 403; age, 60.9 ؎ 1.3 years) and were mostly female (82.5%), while 1.9 ؎ 0.3% had moderate-to-severe COPD (n ‫؍‬ 92, age 39.3 ؎ 1.3) and were mostly male (88.1%). Few nonsmokers with COPD (12.1 ؎ 2.4%) had a previous diagnosis of chronic bronchitis or emphysema. Among nonsmokers, physician-diagnosed asthma increased the risk of mild and especially of moderate-to-severe COPD. Independently of asthma, risk of mild COPD in nonsmokers increased with age (doubling every 12 years), before age 60 was lower among men than women, and was inversely associated with current exposure to tobacco smoke at home and at work. In contrast, the risk of moderate-to-severe COPD in nonsmokers was markedly associated with male gender, peaked in middle age, and was inversely associated with nonwhite ethnicity. COPD risks did not vary by minimal smoking history, longest-held occupation, urban residence, income, allergies, thyroid disease, or Helicobacter pylori antibody. Conclusions: Among nonsmokers, mild and moderate-to-severe COPD are associated with asthma but otherwise have distinct demographic profiles, suggesting that moderate-to-severe disease is not a mere progression of mild COPD.
C
OPD most commonly refers to chronic bronchitis, emphysema, and the subset of asthma characterized by irreversible or partly reversible airflow obstruction. 1 Although the majority of COPD occurs in current or former smokers, the disease also occurs in persons who have never smoked. According to the previous epidemiologic study 2 of COPD in nonsmokers, prevalence is greater among women than men until the age of 60 years, when prevalence ceases to differ by sex. Neither urban residence nor occupational category is associated with COPD in nonsmokers. 2 In the general population, COPD is independently associated with smoking, age, and asthma but not with atopy alone. 3, 4 In addition, genetic predisposition, environmental tobacco smoke, air pollution, Helicobacter pylori infection, and autoimmune thyroid disease have been proposed as risk factors for COPD. [5] [6] [7] [8] [9] The possibility that risk factors for COPD differ according to the severity of disease has not been investigated to date. Using data from a national health examination, the current study identifies and compares risk factors for mild and moderate-tosevere COPD among nonsmokers.
Materials and Methods

Spirometry
In the Third National Health and Nutrition Examination Survey (from 1988 to 1994), a representative sample of the civilian, noninstitutionalized population of the United States consented to an interview (assessing demographic characteristics, medical history, medication use, risk behaviors) and a medical examination (including spirometry and a battery of laboratory tests). 10 Spirometry was conducted by a trained technician either in the mobile examination center or in the home of examinees aged Ͼ 60 years who were unwilling or unable to come to the center. 10 Excluded from spirometry were examinees who had undergone chest or abdominal surgery within 3 weeks or had been hospitalized for myocardial infarction, chest pain, or congestive heart failure within 6 weeks.
Study Population
Current subjects were white, black, or Mexican-American examinees aged 18 to 80 years whose spirometry findings met the reproducibility and reliability criteria of the American Thoracic Society 11, 12 and who provided data on smoking history and height. The upper age limit for the study was chosen to accord with formulas used to derive predicted values of FEV 1 and FVC. 13 Most of the current analysis was restricted to nonsmokers, a group that included both lifelong nonsmokers of cigarettes, cigars, or pipe tobacco and former cigarette smokers with a Ͻ 5 pack-year smoking history who had never smoked cigars or pipes. 9 Pack-years of smoking were calculated taking into account not only the most recent level of daily smoking but also periods of higher usage or abstinence.
Definitions
Using a modification of the Global Initiative for Chronic Obstructive Lung Disease criteria, COPD was defined as a FEV 1 /FVC Ͻ 70% and categorized as mild (FEV 1 Ն 80% of predicted) or moderate to severe (FEV 1 Ͻ 80% predicted). 14, 15 Respiratory symptoms (cough or phlegm on most days for Ͼ 3 months per year, dyspnea on exertion, or wheezing during the past year) and physician diagnosis of asthma, chronic bronchitis, and/or emphysema were recorded; however, none of these was a current criterion for COPD.
Allergies included history of allergic reaction (to insect sting, food, allergy shot, skin test), allergy symptoms (nose, eyes) during the past year, or physician diagnosis of hay fever. Thyroid disease was defined as thyroid stimulating hormone level of Ͻ 0.1 or Ͼ 4.5 mIU/L, a physician diagnosis of goiter or other thyroid disease, or current use of thyroid medication. 16 H pylori antibody was measured by enzyme-linked immunoassay during phase 1 (from 1988 to 1991) of the survey. 17 Current exposure to environmental tobacco smoke was reported separately for the home and the workplace. Exposure at home was present if a household member smoked cigarettes in the home. Exposure at work was present if examinees smelled tobacco smoke at the workplace for Ͼ 4 h/d; lesser daily exposure at work was currently found not to associate significantly with COPD. In addition, long-term occupational exposure to airway irritants was considered likely for persons in the following categories of longest held occupation: extractive or precision production, farm or nursery work, cleaning or building services, laborer, cook, and waiter. Income was analyzed using the poverty index, a ratio of family income to the Census Bureau poverty threshold value for the calendar year. 10 
Statistical Analysis
Sampling weights were taken into account in all analyses (SUDAAN; Research Triangle Institute; Research Triangle Park, NC). Means and percentages were reported with their SEs. Logistic regression analysis was used to identify independent risk factors. Variables found significant (p Ͻ 0.05) in univariate analysis were tested in multivariate analysis and retained if they improved the fit of the model. As suggested by published data 2 and Figure 1 , an interaction term for the effect of sex Ն 60 years and Ͻ 60 years was tested in the model of mild COPD.
Results
Study Sample
Of the 16,238 examinees, aged 18 to 80 years and identified as white, black, or Mexican American, 95.4 Ϯ 0.3% underwent spirometry; of these, 95.2 Ϯ 0.3% produced reproducible and reliable results. After excluding 6 persons with acceptable spirometry who lacked data on smoking history or height, eligibility criteria were met by 13,995 examinees, who represented 155.82 million adults nationwide (female gender, 51.3 Ϯ 0.4%; mean age, 42.2 Ϯ 0.4 years). Among this general sample, one half (48.7 Ϯ 0.9%) were nonsmokers (n ϭ 7,526), who represented 75.95 million adults (female gender, 63.2 Ϯ 0.8%; mean age, 40.1 Ϯ 0.4 years). A Figure 1 . Prevalence of mild and moderate-to-severe COPD in nonsmoking adults, by age and sex. minority of nonsmokers (12.2 Ϯ 0.6%) had smoked Ͻ 5 pack-years before quitting at age 27.2 Ϯ 0.4 years.
Among the general sample (smokers and nonsmokers), mild COPD was present in 8.8 Ϯ 0.3% and moderate-to-severe COPD was present in 4.1 Ϯ 0.3%. Nonsmokers comprised approximately one fourth of COPD cases: 26.1 Ϯ 1.7% of mild COPD cases, and 22.3 Ϯ 3.0% of moderate-tosevere cases. Among nonsmokers, mild COPD was present in 4.7 Ϯ 0.3% (n ϭ 403) and moderate-tosevere COPD was present in 1.9 Ϯ 0.3% (n ϭ 92, of which 31 cases were severe, with FEV 1 23 to 49% predicted). Nonsmokers with and without COPD are described in Table 1 .
Nonsmokers With COPD
The prevalence of mild and moderate-to-severe COPD varied by age and sex (Fig 1) . Most nonsmokers (76.1 Ϯ 3.7%) with mild COPD were older (age Ն 50 years), while most nonsmokers (84.3 Ϯ 5.0%) with moderate-to-severe COPD were younger (age Ͻ 50). Women comprised the majority of nonsmokers with mild COPD, but a small minority of those with moderate-to-severe disease ( Table 1) 
The percentage of nonsmokers who had received a physician diagnosis of asthma increased with the degree of COPD (Table 1) . Nonsmokers' median age at diagnosis of asthma was 10 years (interquartile range, 5 to 28 years). Among nonsmokers with asthma (n ϭ 470), nearly one fourth had some degree of COPD at the time of the survey, 11.3 Ϯ 1.8% having mild COPD, and 12.3 Ϯ 2.9% having moderate-to-severe disease.
Few tory, current exposure to smoking in the home or workplace, urban residence, income, occupation, or education.
Nonsmoker Risk of Mild COPD
Univariate associations with thyroid disease, H pylori antibody, education, and ethnicity (Table 1) became nonsignificant after adjustment for age and sex. Instead, multivariate analysis (Table 2) indicated that risk of mild COPD increased with asthma and with age (doubling every 12 years). Risk was reduced among men before age 60 years; thereafter, risk did not differ significantly by sex. Compared to persons without COPD, mild cases were half as likely to be currently exposed to smoking in the home and one fourth as likely to be currently exposed to smoking in the workplace.
Nonsmoker Risk of Moderate-to-Severe COPD
Asthma was even more strongly associated with moderate-to-severe COPD than with mild COPD (Table 2) . Unlike mild COPD, the risk of moderateto-severe COPD was markedly increased among males, peaked in middle age, and was inversely associated with nonwhite ethnicity. Also unlike mild COPD, moderate-to-severe COPD was not associated with current exposure to smoking at home or at work.
Nonrisks for COPD
Neither mild nor moderate-to-severe COPD among nonsmokers was associated with ever smoking up to 5 pack-years (Table 1) , occupation involving exposure to airway irritants, urban residence, income, or allergies (data not shown). Associations between COPD and asthma (described above) did not vary by age at asthma diagnosis.
Discussion
According to the current study, nonsmokers account for one fourth (24.9 Ϯ 1.4%) of COPD cases in the United States. Similar proportions of nonsmokers have been reported among COPD cases in the United Kingdom and Spain (22.9% and 23.4%, respectively). 9, 18 Few nonsmokers with COPD in the current study had had a previous diagnosis of chronic bronchitis or emphysema. Mild and moderate-tosevere COPD were currently associated with distinct demographic profiles among nonsmokers, suggesting that moderate-to-severe disease is not a mere progression of mild COPD.
The previous epidemiologic study of COPD among nonsmokers employed data from earlier National Health and Nutrition Examination Surveys (from 1971 to 1975, from 1976 to 1980, and from 1982 to 1984). 2 The current study differed from the previous study by defining COPD cases through spirometry rather than reported diagnosis of chronic bronchitis or emphysema, by considering mild and moderate-to-severe COPD separately, by considering asthma and current exposure to tobacco smoke as risk factors, and by reporting the prevalence of respiratory symptoms among COPD cases. In addition, while the previous study defined nonsmokers as persons who had not smoked 100 cigarettes in their lifetime, the current study demonstrated the appropriateness of including among nonsmokers those former smokers with minimal smoking history. 9 As the previous study reported for COPD in general, mild COPD was currently found more prevalent among women than men before age 60 years; in contrast, moderate-to-severe COPD was currently found to affect predominantly men throughout adulthood. The current study confirmed the finding of the previous study 2 of no association between COPD in nonsmokers and occupational category or urban residence.
Among a prior case series of nonsmokers with COPD (n ϭ 22), none was currently exposed to smoking in the home or workplace; however, half had 20-to 30-year histories of such exposure. 9 In the current study, patients with mild COPD tended to avoid current exposure to smoking in the home and at work, but patients with moderate-tosevere COPD did not. Information on exposure history was unavailable. A previous survival analysis 19 detected no increased mortality hazard from moderate-to-severe COPD among nonsmokers. However, current inverse associations with age Ն 60 years and nonwhite ethnicity suggest that moderate-to-severe COPD may indeed compromise survival among specific groups of nonsmokers. Longitudinal studies of COPD in nonsmokers are needed.
The current study confirmed findings from earlier COPD studies not restricted to nonsmokers, specifically independent associations with increasing age and asthma but not with allergy alone. 3, 4 The magnitude of the association between asthma and COPD was currently shown to increase with the severity of COPD.
Limitations of the current study include its cross-sectional nature, limited numbers of nonsmokers with moderate and severe COPD (precluding separate analyses), and nonsampling of nursing home residents and homeless persons. 20 Also, as noted in the footnote to Table 2 , current models explained a small fraction of the risk of mild and moderate-to-severe COPD among nonsmokers, indicating that important risk factors remain to be identified. Data on several proposed risks were not available for the current study: gestational age, birth weight, lower respiratory tract infections before age 7 years, parental smoking during gestation and childhood, exposure to environmental tobacco smoke and other airway irritants throughout adulthood, genetic markers, and family history of COPD. 5, 6, [21] [22] [23] Future spirometric studies, especially if lifetime medical and exposure histories are obtained and subjects are followed up prospectively, will provide a means of testing and improving on current models of COPD risk among nonsmokers.
